Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19273324 | METHOD OF FACILITATING MITIGATION OF COSMETIC IMPERFECTIONS ASSOCIATED WITH FINGERPRINT IMPRESSIONS ON ANODIZED MATERIALS AND ANODIZED MATERIALS TREATED FOR PROVIDING SAME | July 2025 | September 2025 | Allow | 2 | 2 | 0 | No | No |
| 19081211 | FUSION PROTEINS COMPRISING ACID ALPHA-GLUCOSIDASE ENZYMES AND METHODS THEREOF | March 2025 | June 2025 | Allow | 3 | 0 | 0 | Yes | No |
| 18767086 | SUBTERRANEAN WATER BARRIER | July 2024 | February 2025 | Allow | 7 | 1 | 1 | No | No |
| 18752282 | PRODUCTION AND SEPARATION OF 3-HYDROXYPROPIONIC ACID | June 2024 | October 2025 | Allow | 16 | 0 | 0 | No | No |
| 18731620 | Lipase Variants and Microcapsule Compositions Comprising Such Lipase Variants | June 2024 | August 2025 | Allow | 14 | 1 | 0 | Yes | No |
| 18680175 | Production of Lipids and Terpenoids in Auxenochlorella Protothecoides | May 2024 | December 2025 | Allow | 19 | 1 | 0 | No | No |
| 18674362 | INTEGRATED GAS FERMENTATION | May 2024 | March 2025 | Allow | 9 | 1 | 1 | Yes | No |
| 18671324 | KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE | May 2024 | August 2025 | Allow | 14 | 1 | 0 | No | No |
| 18659299 | METHOD OF FACILITATING MITIGATION OF COSMETIC IMPERFECTIONS ASSOCIATED WITH FINGERPRINT IMPRESSIONS ON ANODIZED MATERIALS AND ANODIZED MATERIALS TREATED FOR PROVIDING SAME | May 2024 | July 2025 | Allow | 14 | 1 | 0 | No | No |
| 18636074 | VARIANTS OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AND USES THEREOF | April 2024 | March 2025 | Allow | 11 | 1 | 0 | No | No |
| 18628461 | ENGINEERED DNA POLYMERASE VARIANTS | April 2024 | June 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18616877 | ALPHA SYNUCLEIN SUBSTRATES AND METHODS FOR MAKING AND USING THE SAME | March 2024 | February 2026 | Abandon | 22 | 1 | 1 | No | No |
| 18611354 | ENGINEERED ACID ALPHA-GLUCOSIDASE VARIANTS | March 2024 | August 2025 | Allow | 17 | 1 | 1 | No | No |
| 18609707 | POLYHYDROXYALKANOATE PRODUCTION METHODS AND MATERIALS AND MICROORGANISMS USED IN SAME | March 2024 | April 2025 | Allow | 13 | 1 | 0 | No | No |
| 18600576 | METHOD FOR PRODUCING MULTI-HYDROXY DERIVATIVES OF POLYUNSATURATED FATTY ACIDS | March 2024 | January 2025 | Allow | 10 | 0 | 0 | No | No |
| 18595330 | PROTEINS TOXIC TO HEMIPTERAN INSECT SPECIES | March 2024 | February 2025 | Allow | 11 | 0 | 1 | No | No |
| 18443086 | GENETICALLY ENCODED SYSTEM FOR CONSTRUCTING AND DETECTING BIOLOGICALLY ACTIVE AGENTS | February 2024 | January 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18437009 | ALPHA-AMYLASE COMBINATORIAL VARIANTS | February 2024 | July 2025 | Allow | 18 | 1 | 1 | No | No |
| 18434158 | MUTANT-TYPE RNASE R, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | February 2024 | May 2024 | Allow | 4 | 0 | 0 | Yes | No |
| 18428893 | Method for Producing Phycocyanobilin Using a Recombinant Escherichia Coli | January 2024 | November 2025 | Allow | 21 | 0 | 0 | No | No |
| 18428486 | STEVIOL GLYCOSIDE TRANSPORT | January 2024 | December 2024 | Allow | 11 | 1 | 0 | No | No |
| 18424759 | PFAGO MUTANT PROTEIN WITH MESOPHILIC TARGET NUCLEIC ACID CLEAVAGE ACTIVITY AND APPLICATION THEREOF | January 2024 | June 2024 | Allow | 5 | 0 | 0 | Yes | No |
| 18423707 | PROCESS FOR DYEING TEXTILES AND ENZYMES USED THEREIN | January 2024 | April 2025 | Allow | 14 | 1 | 1 | Yes | No |
| 18419647 | FERMENTATIVE PRODUCTION OF N-BUTYLACRYLATE USING ALCOHOL ACYL TRANSFERASE ENZYMES | January 2024 | March 2025 | Allow | 14 | 1 | 1 | No | No |
| 18418225 | T7 DNA Ligase Variants with Increased Ligation Activity | January 2024 | March 2026 | Allow | 26 | 1 | 1 | No | No |
| 18418068 | CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS | January 2024 | June 2024 | Allow | 5 | 0 | 1 | No | No |
| 18415597 | COMPOSITION OF COMPLEX ENZYME-PROBIOTIC AND ITS APPLICATIONS INTO A METHOD FOR PRODUCING A PREPARATION CONTAINING CHLOROGENIC ACID, PROTOCATECHUIC ACID, AND CAFFEIC ACID HAVING A HIGH CONCENTRATION FROM COFFEE CASCARA | January 2024 | July 2024 | Allow | 6 | 0 | 1 | No | No |
| 18414114 | EVOLUTION OF TALENS | January 2024 | May 2025 | Abandon | 16 | 1 | 1 | No | No |
| 18401382 | SUBTILASE VARIANTS | December 2023 | September 2025 | Allow | 20 | 2 | 0 | No | No |
| 18545514 | OPTIMIZATION OF YEAST HOST CELLS FOR THE PRODUCTION OF HETEROLOGOUS PROTEINS | December 2023 | January 2025 | Allow | 13 | 0 | 0 | Yes | No |
| 18524834 | METHODS AND COMPOSITIONS FOR EFFICIENT GENETIC MODIFICATIONS OF BACILLUS LICHENIFORMIS STRAINS | November 2023 | December 2024 | Allow | 13 | 0 | 0 | No | No |
| 18504863 | POLYPEPTIDES HAVING PHOSPHOLIPASE C ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | November 2023 | July 2025 | Allow | 20 | 1 | 1 | No | No |
| 18499231 | METHOD FOR PREPARING CARBON SOURCE FOR WASTEWATER TREATMENT BY USING KITCHEN WASTE | November 2023 | March 2024 | Allow | 5 | 0 | 0 | No | No |
| 18499560 | SACCHAROMYCES CEREVISIAE STRAIN FOR PRODUCING HUMAN MILK LIPID SUBSTITUTE AND USE THEREOF | November 2023 | June 2025 | Allow | 19 | 1 | 0 | No | No |
| 18499563 | SELECTIVE MODULATION OF PROTEIN-PROTEIN INTERACTIONS | November 2023 | July 2025 | Allow | 20 | 1 | 0 | No | No |
| 18491592 | METHOD FOR TWO-PHASE PARTITIONING PRODUCTION OF MEDIUM-CHAIN FATTY ACID (MCFA) BY DRY ANAEROBIC DIGESTION | October 2023 | April 2024 | Allow | 6 | 1 | 0 | No | No |
| 18490000 | Polypeptides | October 2023 | May 2025 | Allow | 19 | 1 | 1 | No | No |
| 18284349 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | September 2023 | February 2026 | Allow | 28 | 1 | 0 | No | No |
| 18283332 | METHOD FOR PURIFYING PROTEIN DERIVED FROM MEMBRANE PROTEIN COMPLEX | September 2023 | February 2026 | Allow | 29 | 1 | 0 | Yes | No |
| 18467259 | ENGINEERED PHOSPHOPENTOMUTASE VARIANT ENZYMES | September 2023 | June 2025 | Allow | 21 | 1 | 1 | No | No |
| 18464158 | MICROORGANISM OF THE GENUS CORYNEBACTERIUM FOR PRODUCING L-AMINO ACID AND METHOD FOR PRODUCING L-AMINO ACID USING THE SAME | September 2023 | October 2025 | Allow | 26 | 0 | 0 | Yes | No |
| 18278976 | CHEMICAL AND BIOLOGICAL INTEGRATED DEGRADATION PROCESS FOR POLYETHYLENE TEREPHTHALATE (PET), FOR RECYCLING PET | August 2023 | October 2025 | Allow | 26 | 0 | 0 | No | No |
| 18454635 | COMPOSITIONS AND METHODS FOR PRODUCTION OF MYRCENE | August 2023 | March 2025 | Allow | 19 | 1 | 0 | Yes | No |
| 18451665 | GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II | August 2023 | October 2025 | Abandon | 26 | 1 | 1 | No | No |
| 18366786 | SYSTEM AND METHOD FOR PRODUCING A CARBOHYDRATE STREAM FROM A CELLULOSIC FEEDSTOCK | August 2023 | January 2025 | Allow | 18 | 1 | 0 | No | No |
| 18263763 | METHOD FOR MANUFACTURING TRIACYLGLYCEROLS ENRICHED EITHER IN PALMITIC ACID AT SN-2 POSITION OR OLEIC ACID AT SN-2 POSITION | August 2023 | October 2025 | Allow | 26 | 0 | 0 | No | No |
| 18356948 | ENZYMATIC TREATMENT OF ANTHOCYANINS | July 2023 | March 2025 | Abandon | 19 | 0 | 1 | No | No |
| 18261864 | Lipase Mutant and use thereof | July 2023 | September 2025 | Allow | 26 | 0 | 0 | No | No |
| 18349895 | Engineered Biosynthetic Pathways for Production of Histamine by Fermentation | July 2023 | February 2025 | Abandon | 19 | 0 | 0 | No | No |
| 18217828 | SYSTEMS AND METHODS FOR CO-CULTURE OF OXYGEN SENSITIVE BACTERIA AND YEAST | July 2023 | July 2024 | Allow | 13 | 1 | 0 | No | No |
| 18345757 | ENZYMATIC BREAK DOWN OF CHLOROGENIC ACID IN SUNFLOWER-CONTAINING PRODUCTS | June 2023 | January 2026 | Allow | 31 | 1 | 0 | No | No |
| 18342601 | POLYHYDROXYALKANOATE PRODUCTION METHODS AND MATERIALS AND MICROORGANISMS USED IN SAME | June 2023 | January 2025 | Allow | 19 | 1 | 1 | No | No |
| 18342030 | Cleaning Compositions and Uses Thereof | June 2023 | February 2025 | Allow | 20 | 1 | 1 | No | No |
| 18258544 | IMPROVED MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | June 2023 | January 2026 | Allow | 31 | 1 | 0 | Yes | No |
| 18207453 | Fermentative Production of Oligosaccharides By Total Fermentation Utilizing a Mixed Feedstock | June 2023 | February 2025 | Allow | 20 | 2 | 0 | No | No |
| 18256012 | Process For the Detoxification of Lignocellulosic Hydrolysate And Its Use In Synthesizing Xylitol | June 2023 | September 2025 | Allow | 27 | 0 | 0 | No | No |
| 18255832 | Polypeptide Having Beta-Hexosaminidase Activity, and Polynucleotides Coding for the Same | June 2023 | January 2026 | Allow | 32 | 0 | 1 | No | No |
| 18199056 | Cell For Use in Enzyme Assays | May 2023 | November 2024 | Allow | 18 | 2 | 0 | No | No |
| 18318455 | CYSTEINE PROTEASE | May 2023 | March 2025 | Allow | 22 | 1 | 1 | Yes | No |
| 18317683 | Halogenation of Complex Organic Compounds | May 2023 | November 2024 | Allow | 18 | 1 | 0 | No | No |
| 18312017 | DETECTING MICROBIAL INFECTION IN WOUNDS | May 2023 | August 2024 | Allow | 15 | 1 | 0 | No | No |
| 18310636 | MICROORGANISM WITH KNOCK-IN AT ACETOLACTATE DECARBOXYLASE GENE LOCUS | May 2023 | December 2024 | Allow | 19 | 2 | 0 | No | No |
| 18310817 | Detergent Compositions and Uses Thereof | May 2023 | December 2024 | Allow | 19 | 2 | 0 | No | No |
| 18034081 | NOVEL ESTERASES AND USES THEREOF | April 2023 | July 2025 | Allow | 27 | 0 | 0 | No | No |
| 18138472 | OLEIC ACID PRODUCTION IN YEAST | April 2023 | August 2025 | Allow | 28 | 0 | 0 | No | No |
| 18137430 | MODIFIED DAAO ENZYME AND APPLICATION THEREOF | April 2023 | September 2024 | Allow | 17 | 1 | 0 | No | No |
| 18300040 | MICROORGANISMS FOR WASTE TREATMENT | April 2023 | August 2024 | Allow | 16 | 1 | 0 | No | No |
| 18133893 | METHODS AND COMPOSITIONS FOR MODIFICATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE | April 2023 | March 2024 | Allow | 11 | 0 | 0 | No | No |
| 18027984 | RECOMBINANT MICROORGANISM COMPRISING POLYNUCLEOTIDE ENCODING TARGET PRODUCT BINDING PROTEIN FUSED TO SECRETION SIGNAL SEQUENCE, COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING TARGET PRODUCT BY USING SAME | March 2023 | February 2026 | Abandon | 35 | 0 | 1 | No | No |
| 18183669 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | March 2023 | November 2024 | Allow | 20 | 1 | 1 | No | No |
| 18024090 | SYSTEM AND METHOD FOR JOINTLY PRODUCING ERYTHRITOL AND LIQUID SORBITOL BY USING CORN STARCH | March 2023 | July 2025 | Allow | 29 | 0 | 0 | No | No |
| 18173924 | An Improved Process For Xylitol Production | February 2023 | December 2025 | Allow | 34 | 1 | 0 | No | No |
| 18023067 | METHOD OF IMPROVING BIOMASS HIGH-SOLID ENZYMATIC HYDROLYSIS RATE | February 2023 | July 2025 | Allow | 29 | 0 | 0 | No | No |
| 18171737 | ENZYMATIC PROCESS FOR PRODUCTION OF MODIFIED HOP PRODUCTS | February 2023 | August 2024 | Allow | 18 | 1 | 0 | No | No |
| 18022063 | MICROBIAL PRODUCTION OF CANNABINOIDS | February 2023 | September 2025 | Allow | 31 | 0 | 1 | Yes | No |
| 18021788 | ENGINEERED BIOSYNTHETIC PATHWAY FOR PRODUCTION OF 4-AMINOPHENYLETHYLAMINE BY FERMENTATION | February 2023 | January 2026 | Abandon | 35 | 0 | 1 | No | No |
| 18168096 | Polypeptides | February 2023 | February 2024 | Allow | 12 | 0 | 0 | No | No |
| 18102841 | Double Tagged Serratia Marcescens Nuclease | January 2023 | September 2025 | Allow | 31 | 1 | 1 | No | No |
| 18157497 | SUBTILASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | January 2023 | March 2024 | Allow | 14 | 0 | 0 | Yes | No |
| 18006171 | METHODS AND CELLS WITH MODIFYING ENZYMES FOR PRODUCING SUBSTITUTED CANNABINOIDS AND PRECURSORS | January 2023 | November 2025 | Abandon | 34 | 0 | 1 | No | No |
| 18157322 | METHOD OF FACILITATING MITIGATION OF COSMETIC IMPERFECTIONS ASSOCIATED WITH FINGERPRINT IMPRESSIONS ON ANODIZED MATERIALS AND ANODIZED MATERIALS TREATED FOR PROVIDING SAME | January 2023 | March 2024 | Allow | 14 | 0 | 0 | No | No |
| 18014675 | CARBONIC ANHYDRASE COMPLEX AND METHOD FOR BIOIMMOBILIZING CARBON DIOXIDE AND ENHANCING LIPID PRODUCTION THEREBY | January 2023 | October 2025 | Allow | 33 | 1 | 0 | No | No |
| 18013358 | MODIFIED TERPENE SYNTHASES AND THEIR USE FOR PRODUCTION OF PSEUDOPTEROSIN INTERMEDIATES AND/OR PSEUDOPTEROSINS | December 2022 | February 2026 | Allow | 38 | 1 | 1 | No | No |
| 18011604 | Method of Producing Proteins Using a Trichoderma Fungus Strain in Which the CEL1A Gene is Invalidated | December 2022 | September 2025 | Allow | 33 | 1 | 0 | No | No |
| 18068681 | SYSTEM AND METHOD OF BIOCATALYTIC CONVERSION FOR PRODUCTION OF ALCOHOLS, KETONES, AND ORGANIC ACIDS | December 2022 | August 2025 | Allow | 32 | 1 | 0 | No | No |
| 18010666 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | December 2022 | March 2026 | Abandon | 39 | 1 | 1 | No | No |
| 18080163 | PRODUCTION AND SEPARATION OF 3-HYDROXYPROPIONIC ACID | December 2022 | June 2024 | Allow | 18 | 0 | 1 | No | No |
| 18008939 | IMPROVED POLYPEPTIDES CAPABLE OF CONVERTING SUBSTRATE 3-KETO- DEOXYNIVALENOL INTO 3-EPI-DEOXYNIVALENOL | December 2022 | January 2026 | Allow | 38 | 1 | 1 | Yes | No |
| 18000216 | METHOD FOR PRODUCING TARGET PROTEIN | November 2022 | August 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 18055731 | GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS IIIA | November 2022 | March 2025 | Abandon | 28 | 1 | 0 | No | No |
| 17998540 | CONVERSION OF FARNESYLACETONE TO HOMOFARNESYLACETATE BY BAEYER-VILLIGER MONOOXYGENASE | November 2022 | April 2025 | Allow | 29 | 0 | 0 | No | No |
| 17922695 | A METHOD OF PRODUCING AN ORGANIC ACID IN A MIXTURE OF MOLASSES AND CALCIUM HYDROXIDE | November 2022 | June 2025 | Allow | 31 | 0 | 1 | No | No |
| 18049944 | TRANSPOSASE POLYPEPTIDES AND USES THEREOF | October 2022 | June 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 18046466 | Method for Producing a Dairy Product | October 2022 | September 2024 | Allow | 23 | 1 | 0 | No | No |
| 17918040 | PLANT SWEET AND YEAST MSF TRANSPORTER CAPABLE OF TRANSPORTING DIFFERENT SUGARS SIMULTANEOUSLY | October 2022 | March 2026 | Allow | 41 | 1 | 1 | Yes | No |
| 17995778 | CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE | October 2022 | July 2025 | Allow | 34 | 1 | 1 | No | No |
| 17917244 | Production Of Geranyl Diphosphate-Derived Compounds | October 2022 | October 2025 | Allow | 36 | 1 | 1 | Yes | No |
| 17995512 | ENZYME-MEDIATED PROCESS FOR MAKING AMBERKETAL AND AMBERKETAL HOMOLOGUES | October 2022 | August 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17995318 | METHOD FOR MANUFACTURING SN-2 PALMITIC TRIACYLGLYCEROLS | October 2022 | August 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17935491 | Compositions and Methods for Recombinant Biosynthesis of Cannabinoids | September 2022 | August 2025 | Abandon | 35 | 0 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SAIDHA, TEKCHAND.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 48.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner SAIDHA, TEKCHAND works in Art Unit 1652 and has examined 1,699 patent applications in our dataset. With an allowance rate of 80.8%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 24 months.
Examiner SAIDHA, TEKCHAND's allowance rate of 80.8% places them in the 51% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by SAIDHA, TEKCHAND receive 1.12 office actions before reaching final disposition. This places the examiner in the 12% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by SAIDHA, TEKCHAND is 24 months. This places the examiner in the 81% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.
Conducting an examiner interview provides a +18.3% benefit to allowance rate for applications examined by SAIDHA, TEKCHAND. This interview benefit is in the 61% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 37.3% of applications are subsequently allowed. This success rate is in the 85% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 60.6% of cases where such amendments are filed. This entry rate is in the 86% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 36.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 35% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 86.4% of appeals filed. This is in the 80% percentile among all examiners. Of these withdrawals, 63.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 65.0% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 11.8% of allowed cases (in the 95% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.3% of allowed cases (in the 53% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.